In many countries with high-prevalence generalized HIV epidemics, women continue to
acquire HIV during pregnancy and breastfeeding. Women who become infected during this …

HIV acquisition during pregnancy and postpartum periods remains high despite increased
access to and initiation of antiretroviral therapy (ART) in Sub-Saharan Africa [1–5]. There are …

Pre-exposure prophylaxis (PrEP) is a well-established biomedical HIV prevention strategy
and recommended to reduce HIV risk during peri-conception, pregnancy and breastfeeding …

Introduction HIV incidence is high during pregnancy and breastfeeding with HIV acquisition
risk more than doubling during pregnancy and the postpartum period compared to when …

The risk of HIV acquisition is higher during pregnancy and postpartum than other times.
Newly acquired maternal HIV infection associated with high primary viraemia, substantially …

Pregnant and breastfeeding populations are at substantial risk of acquiring HIV in some
settings, yet are underrepresented in clinical trials of new pre-exposure prophylaxis (PrEP) …

Summary Background The World Health Organization (WHO) recommends tenofovir
disoproxil fumarate (TDF)-based oral pre-exposure prophylaxis (PrEP), the dapivirine …

Objective: HIV-uninfected pregnant and breastfeeding women are at high risk of HIV
acquisition, contributing to vertical transmission of HIV. Preexposure prophylaxis (PrEP) is …

ABSTRACT HIV prevention is critically important during pregnancy, however, pre-exposure
prophylaxis (PrEP) is underutilized. We conducted a survey of pregnant and non-pregnant …

Background As pre-exposure prophylaxis (PrEP) becomes more widely used in
heterosexual populations, an important consideration is its safety in infants who are …